Editorial: New drugs for HIV: quo vadis?

Curr Opin HIV AIDS. 2022 Jan 1;17(1):1-3. doi: 10.1097/COH.0000000000000710.

Authors

Charles W Flexner¹, Angela Kashuba²

Affiliations

¹ Divisions of Clinical Pharmacology and Infectious Diseases, School of Medicine and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
² UNC Eshelman School of Pharmacy, UNC Center for AIDS Research, UNC Chapel Hill, North Carolina, USA.

PMID: 34871186
DOI: 10.1097/COH.0000000000000710

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Editorial